← FDA DRUG APPROVALS

FDA ANDA · ANDA084764

DEXAMETHASONE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA084764
TYPE
ANDA
ORIGINAL APPROVAL
1978-03-23
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DEXAMETHASONEDiscontinued
DEXAMETHASONE 0.25MG · TABLET · ORAL

Approval history

2024-06-05Labeling · Supplement 34 · standardAP
1998-12-01Manufacturing (CMC) · Supplement 33AP
1994-12-23Manufacturing (CMC) · Supplement 32AP
1994-10-11Manufacturing (CMC) · Supplement 31AP
1992-04-03Manufacturing (CMC) · Supplement 28AP
1992-04-03Manufacturing (CMC) · Supplement 30AP
1991-06-28Labeling · Supplement 27AP
1991-01-23Labeling · Supplement 26AP
1990-04-02Labeling · Supplement 25AP
1987-08-13Manufacturing (CMC) · Supplement 23AP
1987-08-13Manufacturing (CMC) · Supplement 22AP
1987-03-20Manufacturing (CMC) · Supplement 21AP
1984-11-09Manufacturing (CMC) · Supplement 17AP
1984-11-09Manufacturing (CMC) · Supplement 16AP
1983-08-16Manufacturing (CMC) · Supplement 15AP
1983-08-16Manufacturing (CMC) · Supplement 14AP
1982-03-11Manufacturing (CMC) · Supplement 10AP
1978-03-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →